Profile
Dr. Hans Preusting is a Chief Operating Officer at Mendus AB and a Chief Executive Officer at Synerkine Pharma BV.
He is on the Board of Directors at DCPrime BV, Oxyrane UK Ltd. and PharmaCell BV.
Dr. Preusting was previously employed as a Director-Operations & Business Development by Amsterdam Molecular Therapeutics (AMT) Holding NV, a Director-Influenza & Cell Culture Vaccine by Solvay Pharmaceuticals BV, a Manager-Operations by DSM Biologics Holding, Inc., a Chief Development Officer by DegenRx BV, and a Chief Business Officer by uniQure NV.
He received his MBA from Rotterdam School of Management, a doctorate degree from the University of Groningen and a doctorate degree from Rotterdam School of Management.
Hans Preusting active positions
| Companies | Position | Start |
|---|---|---|
| MENDUS AB | Chief Operating Officer | 05/10/2026 |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Chief Executive Officer | - |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology Manufactures cell therapy and regenerative medicine | Director/Board Member | - |
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Develops novel enzyme replacement therapies | Director/Board Member | - |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Director/Board Member | 01/04/2019 |
Former positions of Hans Preusting
| Companies | Position | End |
|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Chief Operating Officer | 11/03/2013 |
Abbott Healthcare Products BV
Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Corporate Officer/Principal | 01/01/2006 |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Chief Operating Officer | 01/01/2003 |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Education of Hans Preusting
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Abbott Healthcare Products BV
Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Health Technology |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology Manufactures cell therapy and regenerative medicine | Health Technology |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Commercial Services |
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Develops novel enzyme replacement therapies | Health Technology |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Rotterdam School of Management
Rotterdam School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Health Technology |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Commercial Services |
- Stock Market
- Insiders
- Hans Preusting
















